Bangkok, Thailand – June 5, 2025
Vega Stem Cell is pleased to announce its appointment as one of the first official distributors of “Please,” a newly FDA-approved oral Sildenafil medication in Thailand, distributed by DKSH—a global leader in healthcare logistics. This partnership represents a significant milestone in the evolving treatment landscape for erectile dysfunction (ED), integrating conventional pharmacotherapy with advanced regenerative medicine.
The introduction of “Please” into the Thai market provides patients with a clinically proven, high-quality solution for ED. At the same time, Vega Stem Cell’s expertise in stem cell therapy offers a complementary, long-term option that targets the underlying causes of sexual dysfunction. Together, these treatments form a dual-approach strategy that aims to improve both immediate and sustained erectile function.
Erectile dysfunction affects millions worldwide and is often associated with chronic conditions such as diabetes, cardiovascular disease, hormonal imbalances, or psychological factors. While oral medications like Sildenafil remain a standard treatment, many patients are now exploring regenerative therapies for longer-term solutions.
“Please” offers rapid improvement in erectile function by enhancing blood flow and responsiveness. Manufactured to strict pharmaceutical standards, it ensures reliability and consistent results—setting it apart from many generic alternatives. As part of its comprehensive ED care strategy, Vega Stem Cell includes “Please” in its therapeutic offerings to provide immediate symptom relief while upholding its commitment to safety and clinical quality.
However, oral medications primarily address symptoms rather than the underlying physiological damage. Stem cell therapy, particularly with mesenchymal stem cells (MSCs), is gaining recognition for its ability to regenerate vascular tissues, encourage nerve repair, and stimulate new blood vessel formation—all essential components of healthy erectile function. Clinical research has shown promising results, with many patients reporting improved natural erections, increased sensitivity, and enhanced vascular health.
By combining Sildenafil with stem cell injections, Vega Stem Cell offers a hybrid treatment model that delivers both fast-acting relief and long-term regenerative benefits. This approach is especially valuable for men with severe ED or those seeking to reduce reliance on medication.
Erectile function involves a complex interplay of blood vessels, nerves, muscles, and mental health. Any damage to these systems—whether from aging, chronic illness, or injury—can impair performance. Stem cell therapy involves harvesting regenerative cells from sources such as adipose tissue or bone marrow, processing them under sterile conditions, and injecting them into the corpus cavernosum of the penis. These cells then release healing factors that help restore erectile function naturally.
Patients often report gradual improvements in sexual performance, including stronger erections, better libido, and reduced dependence on pharmaceutical aids. For younger men or those in early stages of ED, stem cell therapy may offer a way to prevent the condition from worsening.
The combined use of “Please” and stem cell therapy reflects Vega Stem Cell’s dedication to delivering well-rounded, evidence-based treatment. This integrative model aligns pharmacological efficiency with the restorative power of regenerative medicine, ensuring a more sustainable and individualized approach to ED care.
Founded in 1865, DKSH (DiethelmKellerSiberHegner) is a renowned Market Expansion Services company with operations across Asia, Europe, and the Americas. Headquartered in Zurich, DKSH employs over 32,000 professionals and has built a strong reputation for pharmaceutical distribution, regulatory expertise, and healthcare product management. The company’s introduction of “Please” to the Thai market underscores its commitment to delivering safe and innovative therapies to emerging markets.
As awareness around male sexual health continues to grow and stigma diminishes, demand for discreet, effective ED treatments is rising. Thailand’s advanced healthcare system and reputation as a regional wellness hub make it well-positioned to serve this growing market.
Through its partnership with DKSH, Vega Stem Cell ensures that patients across Thailand and the broader ASEAN region have access to leading-edge ED care. Whether seeking short-term performance enhancement or long-term recovery, patients can rely on a confidential, professional, and medically supervised experience.
Vega Stem Cell remains at the forefront of regenerative solutions for sexual health, anti-aging, and hormonal balance. Its commitment to innovation is reflected in its continuous investment in clinical research, advanced technologies, and patient-centered treatment protocols.
By securing the distribution of DKSH’s newly approved Sildenafil product “Please,” Vega Stem Cell enhances its offerings and reaffirms its role as a leader in regenerative healthcare. The integration of fast-acting medication with regenerative cell therapy signals a new standard in treating ED.
About Vega Stem Cell
Vega Stem Cell is a leading regenerative medicine center based in Bangkok, Thailand. Specializing in stem cell therapy for orthopedic issues, sexual health, ovarian rejuvenation, and anti-aging treatments, the clinic operates with a strong network of medical and laboratory partners. With a focus on safety, innovation, and patient outcomes, Vega provides customized care based on global clinical standards.
Contact Information
Vega Medical Services
3/6, The Primary 101, Soi Lad Phrao 101,
Lad Phrao Road, Khlong Chan, Bang Kapi District,
Bangkok 10240, Thailand
Email: vegastemcell@gmail.com
Tel & WhatsApp: +66 (0) 86 691 6915